Evidence map›Paper›PMID 19437487›Full record

ArticleHepatology (Baltimore, Md.)2009

Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model.

Ping Zhou, Sara Hohm, Yetunde Olusanya, David A Hess, Jan Nolta

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cell fusion in the liver, revisited.World journal of hepatology · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  15. Article
  16. Article
  17. A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo.Clinical cancer research : an official journal of the American Association for Cancer Research · 2011
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ping ZhouStem Cell Program, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Sara Hohm
Yetunde Olusanya
David A Hess
Jan Nolta
University of California Davis Medical Center · USWashington University in St. Louis · USRobarts Clinical Trials · CA

Funding

Immunodeficient Mouse Model of Stem Cell PlasticityR01DK061848 · NIDDK · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 2001 to 2009
$2.7M
Functional dissection of human A-MSC vs BM-MSC phenotypeR01HL073256 · NHLBI · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 2003 to 2010
$2.3M
NHLBI NIH HHS R01 HL073256NHLBI NIH HHS R01HL073256NIDDK NIH HHS R01 DK061848NIDDK NIH HHS R01DK61848
6 · The paper itself

Abstract

unlabelledHuman cord blood stem cells (hCBSCs) have been reported to generate hepatocyte-like cells and thus hold promise for repairing damaged liver. However, the frequency of hCBSC-derived hepatocytes varies tremendously between different studies, and it is still controversial as to whether hCBSC-derived cells can transdifferentiate into hepatocytes or simply fuse to recipient hepatocytes. We used the beta-glucuronidase-deficient nonobese diabetic/severe combined immunodeficient/mucopolysaccharidosis type VII (NOD/SCID/MPSVII) mouse model for better identification of engrafted cells. We transplanted lineage-depleted human umbilical cord blood-derived cells with high aldehyde dehydrogenase activity (ALDH(hi)Lin(-)) into irradiated NOD/SCID/MPSVII mice followed by carbon tetrachloride administration to induced liver damage. ALDH(hi)Lin(-) cells were efficiently engrafted in the recipient mouse livers and improved recovery of the mice from toxic insult. The percentage of human cells in these livers ranged between 3% and 14.2% using quantitative real-time polymerase chain reaction. Furthermore, human-originated cells expressing liver-specific alpha1-antitrypsin messenger RNA, albumin and hepatocyte nuclear factor 1 protein were detected in the recipient livers. Interestingly, human versus murine centromeric fluorescent in situ hybridization analysis on the liver sections demonstrated that most human cells were not fused to mouse cells. However, the majority of the human originated albumin-expressing cells also carried mouse genetic material, hence were the product of cell fusion.

conclusionhCBSCs or their progeny may home to the injured liver and release trophic factors that hasten tissue repair, whereas fusion of these cells with hepatocytes may occur rarely and contribute to a lesser extent to liver repair.

Indexed as

Cord Blood Stem Cell TransplantationAldehyde DehydrogenaseAnimalsDisease Models, AnimalHepatocytesHumansLiver DiseasesMiceStem CellsAldehyde Dehydrogenase

Identifiers

PMID19437487
PMCPMC3030962
OpenAlexW2082929405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.